SUMMARY

Internal Title: Principal Scientist I
The Biomarker Development (BMD) group at the Novartis Institutes for BioMedical Research (NIBR) is seeking an Imaging Expert to join our Clinical Imaging team and actively provide scientific, technical and operational support on the optimal use of imaging in drug development. Be part of an imaging department with deep expertise in structural and molecular biomarkers and their application in clinical and translational development. You will interact with clinical trial teams to establish the role of imaging endpoints along novel biological mechanisms across diverse therapeutic areas. The role offers a wide view of molecules across various stages as they transition from research to early development and subsequently to P2-3 trials. As a part of building imaging endpoints, the role also provides unique exposure to variety of other critical biomarkers (soluble and genetics) for an integrated view of identifying unique patient populations and novel readouts of efficacy and safety.

LI-Hybrid

MAJOR ACCOUNTABILITIES INCLUDE:

• Act as an internal expert in PET and SPECT supporting pre-clinical and clinical programs
• Partner with internal senior imaging experts in Oncology and General Medicine to develop and execute “fit for purpose” imaging strategy
• Implement imaging in clinical trials to add critical insights on patient eligibility, efficacy, safety, and mechanism of action
• Collaborate and execute imaging readouts with internal operational support and external contract research organizations (CRO).
• Ensure quality and timely execution of imaging trials to deliver critical drug development decisions; be agile and responsive to clinical teams during the course of design, execution and interpretation of imaging trials.
• Develop and manage network of external experts; be able to synthesize optimal inputs and customize for specific protocols.
• Collaborate with Research teams to develop and lead translational imaging studies.
• Drive molecular imaging and ligand development from late pre-clinic to clinic
• Identify and/or develop novel imaging techniques and endpoints and implement them into clinical trials

MINIMUM REQUIREMENTS:

• PhD or MD or MD/PhD with experience in PET/SPECT Imaging in academia or industry
• Must have technical knowledge of PET and SPECT as applied to in-life readouts (preclinical and/or clinical)
• Experience in clinical Radioligand/Radiopharmaceutical Therapy (RLT/RPT) is a plus
• Expertise in Radiochemistry, novel ligand development from bench to clinic is a plus
• Experience in Regulatory submission, FIH , Dosimetry and receptor occupancy of molecular ligands is a plus
• Ability to balance external science (e.g., literature, KOL inputs) with optimal needs in projects
• Understanding of clinical trial design, statistics for endpoints and clinical data flow is a plus
• Proactive, self- motivated and independent working style. Used to work in a multidisciplinary team and understand the needs and goals of the broader organization
• Ability to drive for results and success with a sense of urgency. Willing to be held accountable and take personal responsibility for outcomes
• Should be excited to work in a highly matrixed, highly supportive organization.
• Proficiency in English with strong communication skills required

Please refer the Job description for details